On most evenings at a diabetes clinic, the conversation eventually circles back to the same word: cost. Not calories, not carb counts, cost. For many patients, medicines like Ozempic have hovered in ...

On Feb. 27, reporters Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are saying about the health risks and benefits and how it ...

Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

— Adrian García, CEO of Saya Bio. MEXICO CITY, MEXICO, January 26, 2026 /EINPresswire.com/ — Saya Biologics (Saya Bio), a Mexican biopharmaceutical company ...

Oklahomans who purchased certain generic prescription drugs between 2009 and 2019 may be eligible for compensation after two pharmaceutical companies agreed to pay $17.85 million to settle allegations ...

As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...

“Congress… evidently viewed that prospect [of off-label, patented uses] as an acceptable cost of expedited competition with respect to lawful unpatented uses.” – U.S. Solicitor General On Friday, the ...

Cuban said the high fees the FDA charges to approve generic drugs are a major barrier to manufacturing lower-priced generics in the United States, according to the report. Cuban said Cost Plus Drugs, ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

WASHINGTON, Dec 3 (Reuters) - AT&T (T.N), opens new tab and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of orchestrating an ...